secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alkermes plc. (ALKS)
CIK:        0001520262
Form:       8-K
Filed at:   2024-10-09T23:59:59+00:00
Accession:  0000950170-24-113740
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alkermes hosts investor event to review orexin portfolio and development strategy
--------------------------------------------------------------------------------

- Presentation reviewed Alkermes' orexin portfolio on October 9, 2024.
- No specific financial or clinical data disclosed in the furnished exhibit.
- Investor event focused on development strategy for orexin programs.
- Filing under Item 7.01 (Regulation FD) with presentation as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024113740/0000950170-24-113740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024113740/alks-20241009.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-113740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer